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Abstract
 
In developing lymphocytes, the recombination activating gene endonuclease cleaves DNA be-
tween V, D, or J coding and recombination signal (RS) sequences to form hairpin coding and
blunt RS ends, which are fused to form coding and RS joins. Nonhomologous end joining
(NHEJ) factors repair DNA double strand breaks including those induced during VDJ recombi-
nation. Human radiosensitive severe combined immunodeficiency results from lack of Artemis
function, an NHEJ factor with in vitro endonuclease/exonuclease activities. We inactivated 
 
Ar-
temis
 
 in murine embryonic stem (ES) cells by targeted mutation. Artemis deficiency results in
impaired VDJ coding, but not RS, end joining. In addition, Artemis-deficient ES cells are sen-
sitive to a radiomimetic drug, but less sensitive to ionizing radiation. VDJ coding joins from Ar-
temis-deficient ES cells, which surprisingly are distinct from the highly deleted joins consistently
obtained from DNA-dependent protein kinase catalytic subunit–deficient ES cells, frequently
lack deletions and often display large junctional palindromes, consistent with a hairpin coding
end opening defect. Strikingly, Artemis-deficient ES cells have increased chromosomal instabil-
ity including telomeric fusions. Thus, Artemis appears to be required for a subset of NHEJ reac-
tions that require end processing. Moreover, Artemis functions as a genomic caretaker, most
notably in prevention of translocations and telomeric fusions. As Artemis deficiency is compati-
ble with human life, Artemis may also suppress genomic instability in humans.
Key words: Artemis • DNA repair • genomic instablility • telomere fusions • VDJ 
recombination
 
Introduction
 
DNA double strand breaks (DSBs)
 
* 
 
are generated by dam-
aging agents, such as ionizing radiation (IR), or as interme-
diates in normal DNA metabolism. If unrepaired or
improperly repaired, DSBs can lead to cell death or chro-
mosomal damage, including translocations (1). In mamma-
lian cells, DSBs are predominantly repaired by one of two
pathways (for review see reference 2), homologous recom-
bination, or nonhomologous end joining (NHEJ). In addi-
tion, NHEJ is also used to repair DSBs that arise during
early lymphocyte development in the context of VDJ re-
combination (for review see reference 3). The NHEJ path-
way contains six known members including Ku70, Ku80,
XRCC4, DNA ligase 4 (Lig4), DNA-dependent protein
kinase catalytic subunit (DNA-PKcs), and Artemis (for re-
view see reference 3). Previous gene targeted mutation
studies have examined all NHEJ factors except Artemis. In
addition to other defects (see below), NHEJ deficiency can
lead to increased genomic instability (4–11). Moreover,
NHEJ deficiencies, particularly in the context of cell cycle
checkpoint deficiencies, cause increased tumorigenesis (1,
8, 10, 12–19). Ku70, Ku80, and DNA-PKcs are also re-
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tral karyotyping.T
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quired for the protection and maintenance of mammalian
chromosome ends (for review see reference 20). Ku70,
Ku80, and DNA-PKcs deficiencies result in increased lev-
els of telomeric fusions (5, 6, 21–24), a phenotype indica-
tive of telomere deprotection or defective telomere “cap-
ping.” In addition, Ku70 and Ku80 may function in
regulating proper telomere length (7, 22–24). However,
their precise roles in this process are not yet clear.
VDJ recombination is the process by which germline V,
D, and J segments are assembled into complete Ig and
TCR variable region genes (3, 25). RAG-1 and RAG-2
(RAG) initiate VDJ recombination by introducing DSBs
between a pair of participating V, D, or J coding segments
and flanking recombination signal (RS) sequences. RAG-
mediated cleavage generates two types of end structures:
blunt, 5
 
  
 
phosphorylated RS ends and covalently closed
hairpin coding ends. RAG-generated RS ends are precisely
joined with no loss of nucleotides. In contrast, hairpin cod-
ing ends must be processed before ligation, with opening
normally occurring at or within several nucleotides of the
apex (25). Hairpin opening at points other than the apex
results in overhanging flaps, which if incorporated into the
join form nongermline-encoded palindromic (P) nucle-
otide additions that normally range from 1–2 bp in length
(for review see references 25 and 26). In addition,
“N-region” nucleotides might be added to joins by termi-
nal deoxynucleotidyl transferase. Finally, a small number of
nucleotides can be deleted from coding sequences, which
along with P nucleotides and N-regions are a major source
of somatic diversification of the Ig and TCR repertoire.
NHEJ is required to seal both RS and coding ends (for re-
view see reference 3).
Murine cells deficient in Ku70, Ku80, XRCC4, and
Lig4, the four evolutionarily conserved NHEJ factors, ex-
hibit premature senescence, sensitivity to agents that induce
DSBs, and severely impaired VDJ recombination with re-
spect to both coding and RS join formation (for review see
reference 3). Inactivation of any of these four genes in mice
leads to multiple defects including growth deficiency,
SCID, and increased neuronal apoptosis. The precise func-
tions of the various NHEJ components are not fully char-
acterized. However, Ku70 and Ku80 are DNA end bind-
ing proteins, which upon binding to DSBs, can interact
with and activate DNA-PKcs to generate the DNA-PK
holoenzyme (for review see reference 2). DNA-PKcs defi-
ciency also results in a SCID phenotype due to impaired
VDJ recombination. However, DNA-PKcs–deficient cells
do not exhibit growth defects, have variable IR sensitivity,
and have severely impaired coding joining but relatively
normal RS joining (27–29). The difference in severity of
the Ku, XRCC4, and Lig4 deficiencies versus DNA-PKcs
deficiencies suggests that the conserved NHEJ factors have
functions independent of DNA-PKcs.
A precise role for DNA-PKcs has been difficult to eluci-
date as its in vivo kinase substrates are not known. How-
ever, DNA-PKcs has been proposed to function in end
processing, potentially including hairpin opening as sug-
gested by accumulation of covalently sealed hairpin ends in
DNA-PKcs–deficient thymocytes (30, 31). Lack of such a
function could indirectly lead to unusually large P nucle-
otide additions (30). Such elements are found in coding
joins from DNA-PKcs–deficient cells (32–38). In this re-
gard, several findings have suggested that putative DNA-
PKcs hairpin opening functions may involve Artemis.
Artemis was discovered as the mutated gene in human
radiosensitive T
 
  
 
B
 
  
 
SCID (RS-SCID; reference 39), a
disease characterized by lack of B and T lymphocytes and
increased radiosensitivity of bone marrow cells and skin
fibroblasts (40–42). VDJ recombination substrate assays of
RS-SCID fibroblasts demonstrated that Artemis, like
DNA-PKcs, is required primarily for coding versus RS
joining in human cells (39, 42). Moreover, DNA-PKcs
forms a complex with and phosphorylates Artemis in vitro,
leading to the activation of an endonuclease activity that
can cleave RAG-generated hairpins (43). The latter find-
ings led to the suggestion that Artemis–DNA-PKcs com-
plex may serve an end processing function required for a
subset of NHEJ events. In this study, we have generated
Artemis-deficient murine embryonic stem (ES) cells to fur-
ther examine the role of Artemis in VDJ recombination,
DNA repair, and genomic stability.
 
Materials and Methods
 
Generation of Artemis-deficient ES Cells.
 
Two independent
clones containing a single targeted Artemis allele (44) were se-
lected in increasing concentrations of G418 as previously de-
scribed (45). Clones were screened with a 3
 
  
 
probe and double
knockout cells were identified by their loss of the 15.1-kb germ-
line band and retention of the 10-kb targeted band.
 
RT-PCR Analysis.
 
Total RNA was isolated from TC1,
Art
 
 
 
/ N
 
, and Art
 
N/N 
 
ES cells that had been passaged at least twice
in the absence of feeder cells using Trizol (GIBCO BRL) and
cDNA was made using Superscript II reverse transcriptase. The
cDNA was then subjected to PCR as previously described (43).
 
DNA Damage Repair in Artemis-deficient ES cells.
 
ES cells of
indicated genotypes were passaged at least twice in the absence of
feeder cells. For IR sensitivity, cells were exposed to indicated
doses of 
 
  
 
rays from a 
 
137
 
Cs source, plated at various dilutions,
and then cultured for 7 d. For bleomycin sensitivity, ES cells
were plated at various dilutions 16–24 h before exposure to indi-
cated doses of bleomycin for 72 h. Cells were then allowed to re-
cover in drug-free ES cell media for 4 d. For mitomycin C
(MMC) sensitivity, ES cells were plated at various dilutions 16–
24 h before exposure to indicated doses of MMC for 1 h, and al-
lowed to recover in drug-free ES cell media for 7 d. Surviving
colonies were stained with crystal violet and counted. Cells were
plated in duplicate at three different dilutions and numbers of sur-
viving colonies were averaged for each point. Percent survival
was calculated as the number of treated colonies over untreated
control. Data presented represents the average of three indepen-
dent experiments.
 
Transient VDJ Recombination Assays.
 
Assays were performed
as previously described (46). In brief, 8 
 
  
 
10
 
6 
 
ES cells were plated
onto 10-cm gelatinized dishes and allowed to attach for 6–8 h.
Full-length RAG-1 and RAG-2 expression constructs (36) and
the pJH290 coding joining or pJH200 RS joining substrate plas-
mids (47) were transfected into the cells using the calcium phos-
phate method. The cells were harvested 48 h after transfectionT
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and the plasmids were isolated by alkaline lysis and then elec-
troporated into 
 
Escherichia coli 
 
MC1061. VDJ recombination effi-
ciencies were determined by calculating the ratio of 250 
 
 
 
g/ml
amphenicol- and 20 
 
 
 
g/ml chloramphenicol-resistant colonies to
amphenicol-resistant colonies. The fidelity of the RS joins was
determined by PCR amplification of the recombining segment of
pJH200 and subsequent digestion of the products with ApaLI.
Coding join sequences were determined by isolating individual
recombined pJH290 clones from the double selection plates and
nucleotide sequencing.
 
Genomic Instability Assays.
 
ES cells were passaged at least two
times in the absence of feeder cells. TC1, XRCC4
 
 
 
/
 
 
 
, and Art
 
N/N
 
cells (3 
 
  
 
10
 
6 
 
cells) were plated on 10-cm gelatinized dishes and
cultured for 24 h. The cells were exposed to 150 and 300 rads of 
 
 
 
radiation from a 
 
137
 
Cs source and then allowed to recover for 24 or
48 h as indicated. Unirradiated ES cells were cultured as described
above without exposure to IR. Colcemid (KaryoMAX Colcemid
solution; GIBCO BRL) was added to the cultures for 2 h and then
the cells were harvested and fixed. Chromosomal aberrations were
visualized either by staining with DAPI or by chromosome paint-
ing using spectral karyotyping (SKY)™ paints and analyzed using a
Nikon Eclipse microscope equipped with an Applied Spectral Im-
aging interferometer and 40
 
 
 
 and 63
 
 
 
 objectives.
 
Fluorescence in Situ Hybridization.
 
Fluorescence in situ hybrid-
ization analysis of telomere sequences were performed as previ-
ously described (48) using a Cy3-labeled (CCCTAA)
 
3 
 
peptide
nucleic acid probe (Applied Biosystems). Chromosomal fusions
were analyzed using a Nikon Eclipse microscope.
 
Online Supplemental Material.
 
Fig. S1 shows sequences of
coding joins recovered from Art
 
N/N
 
 and DNA-PKcs
 
N/N
 
 ES cells
complemented with human Artemis cDNA and murine DNA-
PKcs cDNA expression constructs, respectively. Fig. S2 shows a
representative Art
 
N/N
 
 metaphase containing a short-arm telomeric
fusion. The online supplemental figures are available at http://
www.jem.org/cgi/content/full/jem.20021891/DC1.
 
Results
 
Generation of Artemis-deficient ES Cell Lines.
 
Several dif-
ferent human 
 
Artemis
 
 mutations have been identified (39,
49) and all appeared to result in a null phenotype (Fig. 1
A). We designed a targeting strategy to mimic one such
mutation in murine ES cells by replacing exons 5 and 6 of
the 
 
Artemis
 
 gene with a neomycin resistance (Neo
 
R
 
) gene
(Fig. 1 A; reference 44). Successfully targeted TC1 ES cell
clones were subjected to selection in increased concentra-
tions of G418 to obtain homozygous 
 
Artemis
 
 knockout ES
cell lines (Art
 
N/N
 
; reference 50). Clones were judged to be
homozygous for the targeted mutation based on the loss of
a 15-kb germline band and appearance of a 10-kb band by
Southern blot analysis (Fig. 1 B). Two of the Art
 
N/N 
 
ES cell
clones were subcloned and used in subsequent analyses. No
obvious growth differences were observed between Art
 
N/N
 
and TC1 ES cells (not depicted). RT-PCR analyses con-
firmed that the Art
 
N/N 
 
cells fail to make a transcript con-
taining exons 1–12 (Fig. 1 C).
 
Artemis- and DNA-PKcs–deficient ES Cells Exhibit Similar
Sensitivities to DNA Damage Agents.
 
To determine the
impact of Artemis deficiency on IR sensitivity, we com-
pared the radiosensitivity of wild-type (TC1), Art
 
N/N
 
,
DNA-PKcs
 
N/N
 
, and XRCC4
 
 
 
/
 
  
 
ES cells using a colony
survival assay (46, 51). At most, Artemis-deficient ES cells
exhibited mildly increased IR sensitivity similar to that ob-
served for DNA-PKcs–deficient ES cells whereas, as ex-
pected, XRCC4
 
 
 
/
 
  
 
ES cells were clearly hypersensitive
(Fig. 2 and Table I). To assess sensitivity to the radiomi-
metic drug bleomycin, which induces DNA DSBs, ES cells
were exposed to bleomycin for a period of 72 h and then
allowed to recover for 4 d. In comparison to TC1 cells,
XRCC4-, Artemis-, and DNA-PKcs–deficient ES cells all
exhibited significantly increased bleomycin sensitivity (Ta-
ble I). However, Art
 
N/N 
 
and DNA-PKcs
 
N/N 
 
ES cells ap-
peared somewhat less sensitive than XRCC4
 
 
 
/
 
  
 
cells (Ta-
ble I). Together, our results suggest that Artemis, like
DNA-PKcs, has a more restricted role than other NHEJ
factors in repairing DSBs in ES cells (Fig. 2 and Table I;
references 27, 46, and 51). In support of this notion, pre-
liminary studies suggest that Art
 
N/N 
 
ES cells, as opposed to
XRCC4
 
 
 
/
 
  
 
ES cells, did not exhibit significantly increased
sensitivity when exposed to bleomycin for a short period of
time (2 h; unpublished data).
Figure 1. Gene targeted mutation of Artemis. (A)
Schematic representation of the targeting strategy. The
human Artemis cDNA and the predicted truncated
transcript from the ArtN/N targeted mutation are de-
picted. Conserved metallo-  lactamase and   CASP
(reference 78) regions are denoted and mutations iden-
tified in human RS-SCID patients (reference 39) are
indicated.  , point mutations;  , single base deletion;
bars, genomic deletions of exons. (B) Representative
Southern blot analysis of ES cells. Genomic DNA from
the indicated cell lines was digested with BamHI and
hybridized with the 3  probe. The germline BamHI
band is 15 kb and the targeted band is 10 kb. (C) RT-
PCR analysis of transcripts. RT-PCR was performed
on total RNA from ES cells using control ATM prim-
ers (C lanes) and Artemis-specific primers to detect
transcripts containing exons 1–4 (1 lanes) or exons
1–12 (2 lanes).T
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Artemis shares sequence similarity to members of the
metallo-
 
  
 
lactamase superfamily, some of which are re-
quired for repair of interstrand cross-links (ICL; reference
39). Therefore, we measured sensitivity of Art
 
N/N 
 
ES cells
to the ICL-inducing agent, MMC. We observed that nei-
ther Artemis- nor DNA-PKcs–deficient ES cells exhibited
increased sensitivity to MMC (Table I). However, as pre-
viously reported, control ES cells deficient in the base ex-
cision repair factor, ERCC1, were markedly sensitive (Ta-
ble I; references 52 and 53). Additional experiments failed
to reveal increased sensitivity of Art
 
N/N 
 
ES cells to ICL
agents cisplatin and melphalan (not depicted). Thus, we
conclude that Artemis is not required for the resolution of
ICL in ES cells.
 
Artemis Is Required for Efficient VDJ Coding, but Not RS,
Joining in ES Cells.
 
To examine the impact of Artemis
deficiency on coding versus RS joining in murine ES cells,
we used a transient VDJ recombination assay (46, 47).
Wild-type (TC1) and Art
 
N/N 
 
ES cells were transfected with
full-length RAG-1 and RAG-2 expression constructs and
plasmid recombination substrates designed to measure
either coding or RS joining frequencies. Ku70
 
 
 
/
 
 
 
,
XRCC4
 
 
 
/
 
 
 
, and DNA-PKcs
 
N/N 
 
ES cells were assayed as
controls. VDJ recombination on the substrate plasmids acti-
vates expression of the chloramphenicol acetyltransferase
gene by deleting a transcriptional terminator that lies be-
tween the two coding/RS sequences. Relative recombina-
tion levels are determined by transforming plasmids recov-
ered from the ES cells into bacteria and then assaying the
ratio of ampicillin-resistant colonies (total plasmids recov-
ered) versus ampicillin plus chloramphenicol-resistant colo-
nies (recombined plasmids).
We observed that coding joining is substantially impaired
in Artemis-deficient cells compared with wild-type TC1
ES cells (Table II). Defective coding joining in the Arte-
mis-deficient ES cells appeared impaired to a roughly simi-
lar extent to that of DNA-PKcs– or XRCC4-deficient ES
cells (Table II). In contrast to coding joins, levels of RS
joins in Artemis-deficient ES cells were comparable to
those observed in wild-type cells (Table II). Precise RS
joins create the recognition site for the restriction endonu-
clease ApaLI. The fidelity of RS joins recovered from Ar-
temis-deficient cells was assayed by ApaLI digestion of re-
covered plasmids, revealing that the majority of the RS
joins analyzed were precise (31 of 32, 97%, of RS joins
were digested by ApaLI). Thus, Artemis-deficient ES cells
exhibit a severe impairment in coding joining but retain
relatively normal ability to perform accurate RS joining.
To confirm that the coding joining defect observed in
Art
 
N/N 
 
ES cells was specifically due to the inactivation of
 
Artemis
 
, we cotransfected a cDNA construct expressing the
human 
 
Artemis
 
 gene and observed full rescue of coding
joining (Table II). Furthermore, we also fully comple-
mented the DNA-PKcs
 
N/N 
 
coding joining defect with the
murine DNA-PKcs cDNA expression construct (Table II).
 
Coding Joins Recovered from Artemis-deficient ES Cells Are
Qualitatively Distinct.
 
Those coding joins recovered from
Artemis-deficient ES cells, as compared with TC1 and
DNA-PKcs
 
N/N 
 
ES cells were enriched for full-length cod-
ing flanks (45 vs. 20 and 11% for Art
 
N/N
 
, TC1, and DNA-
PKcs
 
N/N 
 
ES cells, respectively; Fig. 3 and not depicted).
Moreover, the majority of coding joins from Artemis-defi-
cient ES cells contained P nucleotides (35 of 60 unique
joins, 58%) in contrast to the relatively small percentage of
joins with P nucleotides from wild-type (5 of 50 joins,
10%) and DNA-PKcs
 
N/N 
 
ES cells (8 of 48 joins, 17%). In
addition, P nucleotide additions observed in coding joins
from Art
 
N/N 
 
ES cells typically ranged from one to seven
nucleotides (mean 
 
  
 
3.6 
 
  
 
3.0 bases) whereas those from
wild-type cells did not exceed two nucleotides. In DNA-
PKcs
 
N/N 
 
ES cells, the majority of P nucleotides were one or
two nucleotides in length, although one long P nucleotide
was observed (Fig. 3). Finally, coding joins containing de-
letions of greater than eight nucleotides from either end
were observed at elevated levels in substrates recovered
from Artemis-deficient versus wild-type ES cells (30 vs.
2%). Coding joins with larger deletions (
 
 
 
8 nucleotides)
comprised the majority of sequences recovered from
DNA-PKcs
 
N/N 
 
ES cells (73%). Overall, coding join se-
quences isolated from DNA-PKcs
 
N/N 
 
ES cells were qualita-
Figure 2. IR sensitivity of Artemis-deficient ES cells. Percent survival
of TC1, ArtN/N, DNA-PKcsN/N, and XRCC4 /  ES cells is plotted as a
function of IR dose (rads). The data represents the average of three inde-
pendent experiments.
 
Table I.
 
Sensitivities of Artemis-deficient ES Cells to DNA 
Damaging Agents
 
Cell line
IR
10–500 rads
 
a
 
Bleomycin
0.01–1 
 
 
 
g/ml
MMC
0.02–1.2 
 
 
 
g/ml
TC1 (wild-type) 140 
 
  50b 0.5   0.03 0.5   0.1
ArtN/N 70   30 0.1   0.06 0.6   0.2
DNA-PKcsN/N 72   13 0.06   0.009 0.4   0.2
XRCC4    22   10 0.03   0.001 ND
ERCC1    ND ND 0.1   0.07
All values are the mean IC50   SD of three independent experiments.
aRange of DNA damaging agent used.
bConcentration/level of DNA damaging agent that inhibited cell sur-
vival by 50% (IC50).T
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Table II. Analysis of Coding and RS Joining in ArtN/N ES Cells
Cell lines (Ampr   Camr)/Ampr Percent Relative level
Experiment 1a
TC1 9,868/2,042,500 0.48 1.0
ArtN/N (82.10.66) 387/862,000 0.04 0.08
ArtN/N (82.10.77) 114/493,500 0.02 0.04
XRCC4    6/52,133 0.01 0.02
Experiment 2
TC1 6,414/1,435,000 0.45 1.0
ArtN/N (82.10.77) 188/547,000 0.03 0.07
DNA-PKcsN/N 11/191,500 0.006 0.01
XRCC4    21/246,500 0.009 0.02
Experiment 3
TC1 2,625/500,000 0.53 1.0
ArtN/N (82.10.66) 270/1,345,000 0.02 0.04
ArtN/N (82.10.77) 164/1,410,000 0.01 0.02
DNA-PKcsN/N 62/1,100,000 0.006 0.01
Ku70    25/300,000 0.008 0.02
Experiment 4
TC1 33/3,199 1.0 1.0
ArtN/N (82.10.66.2) 50/126,000 0.05 0.05
DNA-PKcsN/N 12/90,000 0.01 0.01
Experiment 5
TC1 1,503/503,250 0.30 1.0
ArtN/N (82.10.66.2) 136/346,500 0.04 0.13
DNA-PKcsN/N 66/378,500 0.02 0.07
Experiment 6
TC1 2,499/844,500 0.30 1.0
ArtN/N (82.10.66) 80/107,933 0.07 0.2
ArtN/N (82.10.77) 10/74,133 0.01 0.04
XRCC4    0/36,467  0.003  0.01
Experiment 7
TC1 188/17,667 1.1 1.0
ArtN/N (82.10.66.2) 36/19,000 0.19 0.17
ArtN/N (82.10.77) 48/59,867 0.08 0.07
DNA-PKcsN/N (2-41-3) 9/61,000 0.01 0.009
DNA-PKcsN/N (2-35-2) 4/54,400 0.007 0.006
TC1 (no RAG) 23/70,467 0.03 0.03
  hArt cDNA
ArtN/N (82.10.66.2) 248/17,333 1.4 1.3
ArtN/N (82.10.77) 410/69,133 0.59 0.55
  mDNA-PKcs cDNA
DNA-PKcsN/N (2-41-3) 181/27,667 0.65 0.59
DNA-PKcsN/N (2-35-2) 336/76,900 0.44 0.40
Experiment 8
TC1 3,850/640,000 0.6 1.0
ArtN/N (82.10.66.2) 107/147,000 0.07 0.12
ArtN/N (82.10.77) 70/292,000 0.02 0.04
DNA-PKcsN/N (2-41-3) 17/78,000 0.02 0.04
DNA-PKcsN/N (2-35-2) 12/65,300 0.02 0.04T
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tively similar to the few that we have previously mentioned
(27). However, the large number of sequences analyzed in
this study has allowed us to make more quantitative com-
parisons (see Discussion). Introduction of the human Arte-
mis and murine DNA-PKcs expression constructs into the
respective mutant cell lines fully complemented the defects
as joins recovered from complemented cells were similar
to those of wild-type cells (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20021891/DC1).
Artemis Deficiency Results in Increased Genomic Instability.
To assess the potential role of Artemis in maintenance of
genomic stability, we examined chromosomes by DAPI
staining and SKY. First, we measured the level of spon-
taneous chromosomal abnormalities in DAPI-stained me-
taphases from early passage ArtN/N and XRCC4 /  ES cells
relative to those of TC1 cells (Table III). Two indepen-
dently derived Artemis-deficient ES cell lines were ana-
lyzed and both exhibited significantly increased levels of
chromosomal abnormalities, including chromosomal frag-
ments, fusions, and detached centromeres (Table III).
Thus, Artemis deficiency results in increased spontaneous
genomic instability in ES cells, similar to that observed for
XRCC4 deficiency (Table III, Spontaneous instability).
We also examined levels of chromosomal aberrations in
early passage ES cells that had been exposed to 150 or 300
rads of IR and cultured for 48 h before analysis of recov-
ered metaphases by DAPI staining. Upon exposure to IR,
higher levels of chromosomal abnormalities, in particular
chromosomal fragments and fusions, were observed in Ar-
temis- and XRCC4-deficient cells in comparison to wild-
TC1 (no RAG) 10/146,000 0.007 0.01
  hArt cDNA
ArtN/N (82.10.66.2) 118/6,940 1.7 2.8
ArtN/N (82.10.77) 1,037/148,000 0.7 1.2
  mDNA-PKcs cDNA
DNA-PKcsN/N (2-41-3) 2,389/115,800 2.1 3.4
DNA-PKcsN/N (2-35-2) 1,755/378,900 4.6 7.6
Experiment 1b
TC1 552/107,266 0.51 1.0
ArtN/N (82.10.66) 450/57,533 0.78 1.5
ArtN/N (82.10.77) 551/70,400 0.78 1.5
XRCC4    0/12,467  0.008  0.02
Experiment 2
TC1 5,643/852,500 0.66 1.0
ArtN/N (82.10.77) 4,319/394,500 1.09 1.7
DNA-PKcsN/N 526/141,000 0.37 0.6
XRCC4    6/184,000 0.003 0.005
Experiment 3
TC1 2,011/414,000 0.49 1.0
ArtN/N (82.10.77) 3,540/615,000 0.58 1.2
ArtN/N (82.10.66) 5,240/765,000 0.68 1.4
DNA-PKcsN/N 1,016/659,500 0.15 0.3
Ku70    25/473,500 0.005 0.01
Experiment 4
TC1 108/38,663 0.28 1.0
ArtN/N (82.10.66.2) 585/458,000 0.13 0.5
DNA-PKcsN/N 173/106,000 0.16 0.6
Experiment 5
TC1 902/478,500 0.19 1.0
ArtN/N (82.10.66.2) 1,128/451,400 0.25 1.3
DNA-PKcsN/N 1,559/255,500 0.61 3.2
apJH290 (coding joining) for Experiments 1–8.
bpJH200 (signal joining) for Experiments 1–5.
Table II. Analysis of Coding and RS Joining in ArtN/N ES Cells
Cell lines (Ampr   Camr)/Ampr Percent Relative level
(Continued)T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
559 Rooney et al.
type controls (Table III). Using SKY, a chromosomal
painting technique that allows unambiguous identification
of all murine chromosomes (54), we analyzed the types of
chromosomal abnormalities present in metaphases from
ArtN/N, XRCC4 / , and wild-type ES cells that had been
exposed to 300 rads of IR. We observed that Artemis defi-
ciency, as well as XRCC4 deficiency, resulted in increased
levels of chromosomal fusions and translocations in com-
parison to controls (Table III and Fig. 4). Taken together,
these results demonstrate that Artemis plays a significant
role in maintaining genomic stability.
Telomeric Fusions in Artemis-deficient ES Cells. Previ-
ously, Ku70, Ku80, and DNA-PKcs have been found lo-
calized at telomeric repeat sequences (7, 55) and Ku or
DNA-PKcs deficiencies result in increased telomere fusions
indicating that they may function in telomere capping (5,
6, 21–24). To determine whether Artemis plays a similar
role, we further examined the nature of the chromosomal
fusions observed in Artemis-deficient ES cells using a fluo-
rescent peptide nucleic acid probe, which hybridizes to
telomeric sequences (48). We observed increased numbers
of fusions in Artemis-deficient cells in comparison to TC1
controls, and the majority contained telomeric sequence at
the fusion junctions (Fig. 5 and Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20021891/DC1). We
also found increased telomere fusions in DNA-PKcsN/N
cells as has been previously reported (Fig. 5; references 5, 6,
and 21).
Discussion
Artemis Plays a Role in a Subset of NHEJ Events. We
have generated Artemis-deficient murine ES cells by gene
targeted mutation. In ES cells, Artemis is required for re-
pair of bleomycin-induced DNA DSBs and for mainte-
nance of chromosomal stability including telomeric fusions,
indicating important genomic caretaker functions. As in
RS-SCID (Artemis-deficient) human cells (39, 42, 56) and
DNA-PKcs mutant murine cells (27, 36, 38, 57), VDJ re-
combination substrate coding joining is severely impaired
in Artemis-deficient ES cells, but RS joining is relatively
normal, both quantitatively and qualitatively. Moreover,
VDJ substrate coding joins recovered from Artemis-defi-
cient ES cells are qualitatively distinct from those obtained
from wild-type cells, with a large proportion having P nu-
cleotides. Overall, our observations support the suggestion
that Artemis is a major factor involved in the processing of
hairpin coding ends during VDJ recombination, but is not
required for all NHEJ events (39, 43). The latter point is
emphasized by the occurrence of normal RS joining and
Figure 3. Sequence analysis of VDJ coding joins. Individual Camr/Ampr clones were isolated and sequenced. Top boxes, junctional coding sequences
flanking the left and right RSs; underlined, Potential P elements; underlined/italicized, nucleotides that cannot be unequivocally assigned to either end; cen-
ter column, random insertions; parentheses, potential P element possibly formed subsequent to open and shut join with nucleotide loss; **, homology-
mediated joins; right column, number of clones with the same sequence. (A) ArtN/N coding join sequences. (B) DNA-PKcsN/N coding join sequences. (C)
TC1 coding join sequences. Sequences were obtained from two independently derived ArtN/N and DNA-PKcsN/N ES clones. Independent experiments are
indicated by boxes.T
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lack of severe IR sensitivity in ArtN/N ES cells, as opposed
to the complete RS joining deficiency and severe IR sensi-
tivity observed in XRCC4-deficient ES cells.
VDJ Coding Joins from Artemis-deficient ES Cells Have a
Characteristic Structure. Artemis-deficient ES cells are se-
verely impaired in ability to generate coding joins recover-
able via the standard transient VDJ recombination substrate
assay. Yet, a large proportion of the coding joins recovered
from these cells are relatively normal in that they do not
have large deletions. In this regard, a significant proportion
of attempted coding joins in NHEJ-deficient cells are not
scored by the bacterial drug selection assay (36). Thus, it is
likely that a significant proportion of coding joins in ArtN/N
ES cells are also not rejoined or are joined with large dele-
tions. In this regard, most unselected coding joins formed
in the absence of DNA-PKcs also have extremely large de-
letions (58–64).
Coding joins that were recovered from Artemis-defi-
cient ES cells have a high frequency of large ( 2 bp) P nu-
cleotides and a corresponding enrichment of coding flanks
with no nucleotide loss (Fig. 3). These coding join struc-
tures are reminiscent of those recovered within reporter
constructs transiently transfected into some DNA-PKcs
mutant somatic cells (36–38). Lack of a hairpin opening
function could indirectly lead to coding joins with either
very large deletions or unusually long P elements (30).
Thus, the structure of recovered Artemis-deficient coding
joins is consistent with the notion that these joins result
from a different route of hairpin opening and/or process-
ing, supporting the proposal that Artemis acts directly to
Table III. Artemis-deficient ES Cells Exhibit Increased Genomic Instability
TC1 WT
ArtN/N
(82.10.66)
ArtN/N
(82.10.77) XRCC4   
Spontaneous instability
Metaphases 56 30 21 22
Fragmented chromosomes 1 5 5 6
Detached centromeres 2 5 0 3
Fusions 0 4 3 3
Unusual structures 0 0 0 4
Total anomalies (no. per metaphase) 3 (0.05) 14 (0.47) 8 (0.38) 16 (0.73)
Metaphases with abnormalities (percent) 5 37 38 48
Chromosomal aberrations 48 h after 150 rads IR
Metaphases 24 29 24 26
Fragmented chromosomes 4 9 5 12
Detached centromeres 0 5 2 3
Fusions 2 4 4 8
Unusual structures 0 1 0 0
Total anomalies (no. per metaphase) 6 (0.25) 19 (0.66) 11 (0.46) 23 (0.88)
Metaphases with abnormalities (percent) 25 48 42 54
Chromosomal aberrations 48 h after 300 rads IR
Metaphases 24 29 31 26
Fragmented chromosomes 1 10 11 10
Detached centromeres 2 4 2 3
Fusions 3 12 13 18
Unusual structures 0 1 0 0
Total anomalies (no. per metaphase) 6 (0.25) 27 (0.93) 26 (0.84) 31 (1.19)
Metaphases with abnormalities (percent) 25 59 45 62
SKY analysis of chromosomal aberrations 24 h after 300 rads IR TC1 WT ArtN/N XRCC4   
Metaphases 22 20 22
Fragmented chromosomes 22 12 24
Detached centromeres 1 8 6
Fusions 3 10 20
Translocations 8 21 35
Metaphases with abnormalities (percent) 42 75 82T
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open hairpin coding ends (39, 43). Recently, we confirmed
accumulation of hairpin coding ends in Artemis-deficient
thymocytes (44) as previously observed in DNA-PKcs–
deficient thymocytes (30, 31). Given that Artemis provides
the main route of normal coding end hairpin opening, the
low levels of “normal” coding joins in ArtN/N cells implies
that hairpin coding ends can be opened by a much less effi-
cient, alternative nicking activity. Proposed alternative
nicking activities, based on in vitro studies, include the
RAG-1/2 (RAG) or Mre11/RAD50/NBS1 complexes
(65–68).
Differences between Recovered Coding Joins from Artemis- and
DNA-PKcs–deficient ES Cells. The majority of coding
joins recovered from DNA-PKcsN/N ES cells contained
large deletions with only a few exhibiting P nucleotides
(Fig. 3). These coding join sequences are distinct from
those of ArtN/N ES cells (Fig. 3) and also differ from joins
recovered from certain DNA-PKcs mutant somatic cells in
which a significant proportion contained unusually long P
nucleotides (36–38). Joins recovered from ArtN/N somatic
cells also showed some full-length coding flanks and P nu-
cleotides, although not to the extent observed in ES cells
(44). Although the basis for these differences is unclear,
there are various, nonmutually exclusive possibilities. One
is that there might be factors in ES cells as opposed to so-
matic cells or vice versa, which contribute to the altered
spectrum of coding joints observed in different mutant cell
types. In this context, ES cells do not have normal G1
checkpoints. Alternatively, apparent coding join differences
between different DNA-PKcs mutants may reflect low
level expression of catalytically inactive forms of DNA-
PKcs resulting from certain DNA-PKcs mutations (69, 70),
as opposed to the complete null generated by the DNA-
PKcsN/N  targeted mutation (27). Catalytically inactive
forms of DNA-PKcs may retain residual activities including
interaction with Artemis, potentially sequestering it in in-
active complexes or altering its activities. Ultimately, the
characterization of potential differences with respect to
complete and partially inactivating DNA-PKcs mutations
will require introduction of all mutations into the same cel-
lular and genetic background.
There could be several different explanations for the
striking qualitative differences between coding joins recov-
ered from DNA-PKcsN/N and ArtN/N ES cells. DNA-PKcs
likely has additional functions in the context of the DNA-
PK holoenzyme, possibly in the activation and/or recruit-
ment of other NHEJ factors (2). Thus, in the absence of
Artemis, hairpin coding ends still might be captured within
a DNA-PKcs–mediated synaptic complex (71) and become
available to alternative, potentially DNA-PKcs–activated,
hairpin opening activities. Likewise, in the absence of Arte-
mis, ends opened in the context of a DNA-PKcs complex
might be protected and less frequently processed, for exam-
ple via an Artemis endonuclease or exonuclease activity
(43). Additional studies will be needed to distinguish be-
tween these and other potential possibilities.
DSB Repair Defects in Artemis-deficient ES Cells. ArtN/N
and DNA-PKcsN/N ES cells exhibit markedly increased ble-
omycin sensitivity. However, at most they are mildly IR
sensitive compared with XRCC4- or Ku-deficient ES cells
Figure 4. Chromosomal aberrations in metaphase spreads from irradi-
ated ArtN/N ES cells. (A and B) Metaphase spreads of ArtN/N ES cells 24 h
after 300 rads IR. On the left, DAPI-stained chromosomes are shown.
On the right, SKY analysis is shown. Yellow arrows, chromosomal trans-
locations; red arrow, detached centromeres and chromosomal fragments.
Figure 5. Telomere fusions arise in ArtN/N
ES cells. (A) Telomeric sequence was iden-
tified using a Cy3-labeled peptide nucleic
acid probe in metaphases from ArtN/N,
DNA-PKcsN/N, and TC1 ES cells. (B) Rep-
resentative short-arm telomeric fusion in an
ArtN/N ES cell metaphase. Arrow represents
two telomeric signals located at the point of
fusion between cytogenetically invisible
short arms. Adjacent, nonfused chromo-
somes would show four discrete signals.T
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(46, 51). Among the six known NHEJ factors, only Arte-
mis and DNA-PKcs are not conserved in yeast. One po-
tential explanation for the less profound radiosensitivity of
Artemis- and DNA-PKcs–deficient ES cells, as opposed to
those deficient in evolutionarily conserved NHEJ factors, is
that Artemis and DNA-PKcs are used to process and repair
a subset of DSBs, i.e., ends requiring endonucleolytic pro-
cessing (27, 43). This notion is also consistent with the
requirement for Ku and XRCC4 (46, 51), but not DNA-
PKcs and Artemis, for RS joining in ES cells. In this con-
text, decreased survival of DNA-PKcsN/N and ArtN/N ES
cells observed upon sustained bleomycin exposure may re-
sult from accumulation of a class of DSBs requiring DNA-
PKcs and Artemis for repair. Alternatively, prolonged bleo-
mycin exposure may allow a threshold DSB level to be
reached that can no longer be adequately repaired without
Artemis or DNA-PKcs. Human RS-SCID fibroblasts,
bone marrow cells (40–42), and ArtN/N MEFs (44) are
markedly IR sensitive. Thus, as with DNA-PKcs defi-
ciency (27), Artemis deficiency may exhibit cell type varia-
tion in the degree of its impact on IR sensitivity. Finally,
Artemis-deficient ES cells do not display increased sensitiv-
ity to the ICL agent, MMC, despite sequence similarity to
factors required for repair of ICL (39). Therefore, in mu-
rine ES cells, Artemis appears specifically required for repair
of a subset of DNA DSBs but not for resolution of ICL
Artemis Is Required for Maintenance of Genomic Stability.
Artemis deficiency results in increased genomic instability
in ES cells. The types of chromosomal aberrations ob-
served include chromosomal fragmentation, detached cen-
tromeres, fusions, and translocations. Thus, Artemis plays
an important role as a genomic caretaker. In addition, like
Ku and DNA-PKcs (20), Artemis also may function in
telomere capping based on the increased levels of telomere
fusions observed in Artemis-deficient ES cells. In this re-
gard, it will be of interest to determine potential roles of
Artemis in maintenance of telomere length, as there are
conflicting reports regarding the role of Ku in this context
(7, 23, 24). Although the precise function of Artemis with
respect to telomeres remains unclear, it is intriguing that
Artemis possesses intrinsic exonuclease and endonuclease
activities that are regulated by DNA-PKcs (43). Thus, the
Artemis–DNA-PKcs complex may not only function in
VDJ recombination and general DNA DSB repair, but also
in telomere maintenance.
Genomic instability is a hallmark of tumorigenesis and
mice deficient for Ku70 as well as some lines of DNA-
PKcs–deficient mice are predisposed to T cell lymphomas
(13, 14, 72). Lymphomagenesis caused by NHEJ deficiency
is enhanced by inactivation of cell cycle checkpoints, as
NHEJ/p53 double mutant mice succumb to aggressive
pro–B cell lymphomas during young adulthood (1, 8, 10,
12, 15, 17, 19, 73). To date, inactivating mutations in
XRCC4, Lig4, Ku70, Ku80, or DNA-PKcs have not been
associated with human RS-SCID and several lines of evi-
dence suggest that such mutations in humans may not sup-
port cell growth or survival (51, 74–77). Because Artemis
deficiency is compatible with sustained human life, our
finding that Artemis deficiency leads to genomic instability
in murine cells suggests Artemis as a candidate tumor sup-
pressor gene in humans.
We thank Dr. Craig Bassing for critical reading of the manuscript
and Dr. Roland Kanaar for the gift of ERCC1-deficient ES cells.
This work was supported by National Institutes of Health (NIH)
grants AI35714 and CA92625 to F.W. Alt and AI32524 to D.G.
Schatz. F.W. Alt and D.G. Schatz are Investigators of the Howard
Hughes Medical Institute. S. Fugmann is an Irvington postdoctoral
fellow. J. Sekiguchi is a Special Fellow of the Leukemia and Lym-
phoma Society. D.O. Ferguson is supported by NIH grant K08
HL67580-02.
Submitted: 30 October 2002
Revised: 19 November 2002
Accepted: 5 December 2002
References
1. Ferguson, D.O., and F.W. Alt. 2001. DNA double strand
break repair and chromosomal translocation: lessons from an-
imal models. Oncogene. 20:5572–5579.
2. Jackson, S.P. 2002. Sensing and repairing DNA double-
strand breaks. Carcinogenesis. 23:687–696.
3. Bassing, C.H., W. Swat, and F.W. Alt. 2002. The mecha-
nism and regulation of chromosomal V(D)J recombination.
Cell. 109:S45–S55.
4. Gilley, D., H. Tanaka, M.P. Hande, A. Kurimasa, G.C. Li,
M. Oshimura, and D.J. Chen. 2001. DNA-PKcs is critical for
telomere capping. Proc. Natl. Acad. Sci. USA. 98:15084–
15088.
5. Bailey, S.M., M.N. Cornforth, A. Kurimasa, D.J. Chen, and
E.H. Goodwin. 2001. Strand-specific postreplicative process-
ing of mammalian telomeres. Science. 293:2462–2465.
6. Goytisolo, F.A., E. Samper, S. Edmonson, G.E. Taccioli, and
M.A. Blasco. 2001. The absence of the dna-dependent pro-
tein kinase catalytic subunit in mice results in anaphase
bridges and in increased telomeric fusions with normal telo-
mere length and G-strand overhang. Mol. Cell. Biol. 21:
3642–3651.
7. d’Adda di Fagagna, F., M.P. Hande, W.M. Tong, D. Roth,
P.M. Lansdorp, Z.Q. Wang, and S.P. Jackson. 2001. Effects
of DNA nonhomologous end-joining factors on telomere
length and chromosomal stability in mammalian cells. Curr.
Biol. 11:1192–1196.
8. Difilippantonio, M.J., J. Zhu, H.T. Chen, E. Meffre, M.C.
Nussenzweig, E.E. Max, T. Ried, and A. Nussenzweig.
2000. DNA repair protein Ku80 suppresses chromosomal ab-
errations and malignant transformation. Nature. 404:510–514.
9. Ferguson, D.O., J.M. Sekiguchi, S. Chang, K.M. Frank, Y.
Gao, R.A. DePinho, and F.W. Alt. 2000. The nonhomolo-
gous end-joining pathway of DNA repair is required for ge-
nomic stability and the suppression of translocations. Proc.
Natl. Acad. Sci. USA. 97:6630–6633.
10. Gao, Y., D.O. Ferguson, W. Xie, J. Manis, J. Sekiguchi,
K.M. Frank, J. Chaudhuri, R.A. DePinho, and F.W. Alt.
2000. Interplay of p53 and DNA-repair protein XRCC4 in
tumourigenesis, genomic stability and development. Nature.
404:897–900.
11. Karanjawala, Z.E., U. Grawunder, C.L. Hsieh, and M.R.
Lieber. 1999. The nonhomologous DNA end joining path-
way is important for chromosome stability in primary fibro-T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
563 Rooney et al.
blasts. Curr. Biol. 9:1501–1504.
12. Difilippantonio, M.J., S. Petersen, H.T. Chen, R. Johnson,
M. Jasin, R. Kanaar, T. Ried, and A. Nussenzweig. 2002.
Evidence for replicative repair of DNA double-strand breaks
leading to oncogenic translocation and gene amplification. J.
Exp. Med. 196:469–480.
13. Gu, Y., K.J. Seidl, G.A. Rathbun, C. Zhu, J.P. Manis, N.
van der Stoep, L. Davidson, H.L. Cheng, J.M. Sekiguchi, K.
Frank, et al. 1997. Growth retardation and leaky SCID phe-
notype of Ku70-deficient mice. Immunity. 7:653–665.
14. Li, G.C., H. Ouyang, X. Li, H. Nagasawa, J.B. Little, D.J.
Chen, C.C. Ling, Z. Fuks, and C. Cordon-Cardo. 1998.
Ku70: a candidate tumor suppressor gene for murine T cell
lymphoma. Mol. Cell. 2:1–8.
15. Lim, D.S., H. Vogel, D.M. Willerford, A.T. Sands, K.A.
Platt, and P. Hasty. 2000. Analysis of ku80-mutant mice and
cells with deficient levels of p53. Mol. Cell. Biol. 20:3772–
3780.
16. Gurley, K.E., K. Vo, and C.J. Kemp. 1998. DNA double-
strand breaks, p53, and apoptosis during lymphomagenesis in
scid/scid mice. Cancer Res. 58:3111–3115.
17. Nacht, M., A. Strasser, Y.R. Chan, A.W. Harris, M. Schlis-
sel, R.T. Bronson, and T. Jacks. 1996. Mutations in the p53
and SCID genes cooperate in tumorigenesis. Genes Dev. 10:
2055–2066.
18. Frank, K.M., N.E. Sharpless, Y. Gao, J.M. Sekiguchi, D.O.
Ferguson, C. Zhu, J.P. Manis, J. Horner, R.A. DePinho, and
F.W. Alt. 2000. DNA ligase IV deficiency in mice leads to
defective neurogenesis and embryonic lethality via the p53
pathway. Mol. Cell. 5:993–1002.
19. Zhu, C., K.D. Mills, D.O. Ferguson, C. Lee, J. Manis, J.
Fleming, Y. Gao, C.C. Morton, and F.W. Alt. 2002. Unre-
paired DNA breaks in P53-deficient cells lead to oncogenic
gene amplification subsequent to translocations. Cell. 109:
811–821.
20. de Lange, T. 2002. Protection of mammalian telomeres. On-
cogene. 21:532–540.
21. Bailey, S.M., J. Meyne, D.J. Chen, A. Kurimasa, G.C. Li, B.E.
Lehnert, and E.H. Goodwin. 1999. DNA double-strand break
repair proteins are required to cap the ends of mammalian
chromosomes. Proc. Natl. Acad. Sci. USA. 96:14899–14904.
22. Hsu, H.L., D. Gilley, S.A. Galande, M.P. Hande, B. Allen,
S.H. Kim, G.C. Li, J. Campisi, T. Kohwi-Shigematsu, and
D.J. Chen. 2000. Ku acts in a unique way at the mammalian
telomere to prevent end joining. Genes Dev. 14:2807–2812.
23. Samper, E., F.A. Goytisolo, P. Slijepcevic, P.P. van Buul, and
M.A. Blasco. 2000. Mammalian Ku86 protein prevents telo-
meric fusions independently of the length of TTAGGG re-
peats and the G-strand overhang. EMBO Rep. 1:244–252.
24. Espejel, S., S. Franco, S. Rodriguez-Perales, S.D. Bouffler,
J.C. Cigudosa, and M.A. Blasco. 2002. Mammalian Ku86
mediates chromosomal fusions and apoptosis caused by criti-
cally short telomeres. EMBO J. 21:2207–2219.
25. Schlissel, M.S. 2002. Does artemis end the hunt for the hair-
pin-opening activity in V(D)J recombination? Cell. 109:1–4.
26. Lewis, S.M. 1994. P nucleotides, hairpin DNA and V(D)J
joining: making the connection. Semin. Immunol. 6:131–141.
27. Gao, Y., J. Chaudhuri, C. Zhu, L. Davidson, D.T. Weaver,
and F.W. Alt. 1998. A targeted DNA-PKcs-null mutation
reveals DNA-PK-independent functions for KU in V(D)J re-
combination. Immunity. 9:367–376.
28. Taccioli, G.E., A.G. Amatucci, H.J. Beamish, D. Gell, X.H.
Xiang, M.I. Torres Arzayus, A. Priestley, S.P. Jackson, A.
Marshak Rothstein, P.A. Jeggo, et al. 1998. Targeted disrup-
tion of the catalytic subunit of the DNA-PK gene in mice
confers severe combined immunodeficiency and radiosensi-
tivity. Immunity. 9:355–366.
29. Kurimasa, A., H. Ouyang, L.J. Dong, S. Wang, X. Li, C.
Cordon-Cardo, D.J. Chen, and G.C. Li. 1999. Catalytic sub-
unit of DNA-dependent protein kinase: impact on lympho-
cyte development and tumorigenesis. Proc. Natl. Acad. Sci.
USA. 96:1403–1408.
30. Roth, D.B., J.P. Menetski, P.B. Nakajima, M.J. Bosma, and
M. Gellert. 1992. V(D)J recombination: broken DNA mole-
cules with covalently sealed (hairpin) coding ends in scid
mouse thymocytes. Cell. 70:983–991.
31. Zhu, C., and D.B. Roth. 1995. Characterization of coding
ends in thymocytes of scid mice: implications for the mecha-
nism of V(D)J recombination. Immunity. 2:101–112.
32. Carroll, A.M., and M.J. Bosma. 1991. T-lymphocyte devel-
opment in scid mice is arrested shortly after the initiation
of T-cell receptor delta gene recombination. Genes Dev.
5:1357–1366.
33. Ferrier, P., L.R. Covey, S.C. Li, H. Suh, B.A. Malynn, T.K.
Blackwell, M.A. Morrow, and F.W. Alt. 1990. Normal re-
combination substrate VH to DJH rearrangements in pre-B
cell lines from scid mice. J. Exp. Med. 171:1909–1918.
34. Schuler, W., N.R. Ruetsch, M. Amsler, and M.J. Bosma.
1991. Coding joint formation of endogenous T cell receptor
genes in lymphoid cells from scid mice: unusual P-nucleotide
additions in VJ-coding joints. Eur. J. Immunol. 21:589–596.
35. Kienker, L.J., W.A. Kuziel, and P.W. Tucker. 1991. T cell
receptor gamma and delta gene junctional sequences in SCID
mice: excessive P nucleotide insertion. J. Exp. Med. 174:769–
773.
36. Taccioli, G.E., G. Rathbun, E. Oltz, T. Stamato, P.A. Jeggo,
and F.W. Alt. 1993. Impairment of V(D)J recombination in
double-strand break repair mutants. Science. 260:207–210.
37. Taccioli, G.E., H.L. Cheng, A.J. Varghese, G. Whitmore,
and F.W. Alt. 1994. A DNA repair defect in Chinese hamster
ovary cells affects V(D)J recombination similarly to the mu-
rine scid mutation. J. Biol. Chem. 269:7439–7442.
38. Binnie, A., S. Olson, G.E. Wu, and S.M. Lewis. 1999.
Gamma-irradiation directly affects the formation of coding
joints in SCID cell lines. J. Immunol. 163:5418–5426.
39. Moshous, D., I. Callebaut, R. de Chasseval, B. Corneo, M.
Cavazzana-Calvo, F. Le Deist, I. Tezcan, O. Sanal, Y. Ber-
trand, N. Philippe, et al. 2001. Artemis, a novel DNA dou-
ble-strand break repair/V(D)J recombination protein, is mu-
tated in human severe combined immune deficiency. Cell.
105:177–186.
40. Cavazzana-Calvo, M., F. Le Deist, G. De Saint Basile, D. Pa-
padopoulo, J.P. De Villartay, and A. Fischer. 1993. Increased
radiosensitivity of granulocyte macrophage colony-forming
units and skin fibroblasts in human autosomal recessive severe
combined immunodeficiency. J. Clin. Invest. 91:1214–1218.
41. Nicolas, N., N.J. Finnie, M. Cavazzana-Calvo, D. Papa-
dopoulo, F. Le Deist, A. Fischer, S.P. Jackson, and J.P. de
Villartay. 1996. Lack of detectable defect in DNA double-
strand break repair and DNA-dependent protein kinase activ-
ity in radiosensitive human severe combined immunodefi-
ciency fibroblasts. Eur. J. Immunol. 26:1118–1122.
42. Nicolas, N., D. Moshous, M. Cavazzana-Calvo, D. Papa-
dopoulo, R. de Chasseval, F. Le Deist, A. Fischer, and J.P. de
Villartay. 1998. A human severe combined immunodeficiency
(SCID) condition with increased sensitivity to ionizing radia-T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
564 Requirement for Artemis in DNA Repair and Genomic Stability
tions and impaired V(D)J rearrangements defines a new DNA
recombination/repair deficiency. J. Exp. Med. 188:627–634.
43. Ma, Y., U. Pannicke, K. Schwarz, and M.R. Lieber. 2002.
Hairpin opening and overhang processing by an Artemis/
DNA-dependent protein kinase complex in nonhomologous
end joining and V(D)J recombination. Cell. 108:781–794.
44. Rooney, S., J. Sekiguchi, C. Zhu, H.L. Cheng, J.P. Manis, S.
Whitlow, J. DeVido, D. Foy, J. Chaudhuri, D. Lombard, et
al. 2002. Leaky scid phenotype associated with defective
V(D)J coding end processing in Artemis-deficient mice. Mol.
Cell. 10:1379–1390.
45. Chen, J., R. Lansford, V. Stewart, F. Young, and F.W. Alt.
1993. RAG-2-deficient blastocyst complementation: an assay
of gene function in lymphocyte development. Proc. Natl.
Acad. Sci. USA. 90:4528–4532.
46. Gu, Y., S. Jin, Y. Gao, D.T. Weaver, and F.W. Alt. 1997.
Ku70-deficient embryonic stem cells have increased ionizing
radiosensitivity, defective DNA end-binding activity, and in-
ability to support V(D)J recombination. Proc. Natl. Acad. Sci.
USA. 94:8076–8081.
47. Hesse, J.E., M.R. Lieber, M. Gellert, and K. Mizuuchi. 1987.
Extrachromosomal DNA substrates in pre-B cells undergo
inversion or deletion at immunoglobulin V-(D)-J joining sig-
nals. Cell. 49:775–783.
48. Greenberg, R.A., L. Chin, A. Femino, K.H. Lee, G.J. Gott-
lieb, R.H. Singer, C.W. Greider, and R.A. DePinho. 1999.
Short dysfunctional telomeres impair tumorigenesis in the
INK4a(delta2/3) cancer-prone mouse. Cell. 97:515–525.
49. Li, L., D. Moshous, Y. Zhou, J. Wang, G. Xie, E. Salido, D.
Hu, J.P. de Villartay, and M.J. Cowan. 2002. A founder mu-
tation in Artemis, an SNM1-like protein, causes SCID in
Athabascan-speaking Native Americans. J. Immunol. 168:
6323–6329.
50. Chen, J., M. Trounstine, C. Kurahara, F. Young, C.C. Kuo,
Y. Xu, J.F. Loring, F.W. Alt, and D. Huszar. 1993. B cell de-
velopment in mice that lack one or both immunoglobulin
kappa light chain genes. EMBO J. 12:821–830.
51. Gao, Y., Y. Sun, K.M. Frank, P. Dikkes, Y. Fujiwara, K.J.
Seidl, J.M. Sekiguchi, G.A. Rathbun, W. Swat, J. Wang, et
al. 1998. A critical role for DNA end-joining proteins in both
lymphogenesis and neurogenesis. Cell. 95:891–902.
52. Weeda, G., I. Donker, J. de Wit, H. Morreau, R. Janssens,
C.J. Vissers, A. Nigg, H. van Steeg, D. Bootsma, and J.H.
Hoeijmakers. 1997. Disruption of mouse ERCC1 results in a
novel repair syndrome with growth failure, nuclear abnor-
malities and senescence. Curr. Biol. 7:427–439.
53. Dronkert, M.L., J. de Wit, M. Boeve, M.L. Vasconcelos, H.
van Steeg, T.L. Tan, J.H. Hoeijmakers, and R. Kanaar. 2000.
Disruption of mouse SNM1 causes increased sensitivity to the
DNA interstrand cross-linking agent mitomycin C. Mol. Cell.
Biol. 20:4553–4561.
54. Liyanage, M., A. Coleman, S. du Manoir, T. Veldman, S.
McCormack, R.B. Dickson, C. Barlow, A. Wynshaw-Boris,
S. Janz, J. Wienberg, et al. 1996. Multicolour spectral karyo-
typing of mouse chromosomes. Nat. Genet. 14:312–315.
55. Hsu, H.L., D. Gilley, E.H. Blackburn, and D.J. Chen. 1999.
Ku is associated with the telomere in mammals. Proc. Natl.
Acad. Sci. USA. 96:12454–12458.
56. Moshous, D., L. Li, R. Chasseval, N. Philippe, N. Jabado,
M.J. Cowan, A. Fischer, and J.P. de Villartay. 2000. A new
gene involved in DNA double-strand break repair and V(D)J
recombination is located on human chromosome 10p. Hum.
Mol. Genet. 9:583–588.
57. Lieber, M.R., J.E. Hesse, S. Lewis, G.C. Bosma, N. Rosen-
berg, K. Mizuuchi, M.J. Bosma, and M. Gellert. 1988. The
defect in murine severe combined immune deficiency: join-
ing of signal sequences but not coding segments in V(D)J re-
combination. Cell. 55:7–16.
58. Schuler, W., I.J. Weiler, A. Schuler, R.A. Phillips, N.
Rosenberg, T.W. Mak, J.F. Kearney, R.P. Perry, and M.J.
Bosma. 1986. Rearrangement of antigen receptor genes is
defective in mice with severe combined immune deficiency.
Cell. 46:963–972.
59. Hendrickson, E.A., M.S. Schlissel, and D.T. Weaver. 1990.
Wild-type V(D)J recombination in scid pre-B cells. Mol.
Cell. Biol. 10:5397–5407.
60. Hendrickson, E.A., D.G. Schatz, and D.T. Weaver. 1988.
The scid gene encodes a trans-acting factor that mediates the
rejoining event of Ig gene rearrangement. Genes Dev. 2:817–
829.
61. Kim, M.G., W. Schuler, M.J. Bosma, and K.B. Marcu. 1988.
Abnormal recombination of Igh D and J gene segments in
transformed pre-B cells of scid mice. J. Immunol. 141:1341–
1347.
62. Malynn, B.A., T.K. Blackwell, G.M. Fulop, G.A. Rathbun,
A.J. Furley, P. Ferrier, L.B. Heinke, R.A. Phillips, G.D.
Yancopoulos, and F.W. Alt. 1988. The scid defect affects the
final step of the immunoglobulin VDJ recombinase mecha-
nism. Cell. 54:453–460.
63. Blackwell, T.K., B.A. Malynn, R.R. Pollock, P. Ferrier,
L.R. Covey, G.M. Fulop, R.A. Phillips, G.D. Yancopoulos,
and F.W. Alt. 1989. Isolation of scid pre-B cells that rear-
range kappa light chain genes: formation of normal signal and
abnormal coding joins. EMBO J. 8:735–742.
64. Okazaki, K., S. Nishikawa, and H. Sakano. 1988. Aberrant
immunoglobulin gene rearrangement in scid mouse bone
marrow cells. J. Immunol. 141:1348–1352.
65. Paull, T.T., and M. Gellert. 1998. The 3  to 5  exonuclease
activity of Mre 11 facilitates repair of DNA double-strand
breaks. Mol. Cell. 1:969–979.
66. Paull, T.T., and M. Gellert. 1999. Nbs1 potentiates ATP-
driven DNA unwinding and endonuclease cleavage by the
Mre11/Rad50 complex. Genes Dev. 13:1276–1288.
67. Shockett, P.E., and D.G. Schatz. 1999. DNA hairpin open-
ing mediated by the RAG1 and RAG2 proteins. Mol. Cell.
Biol. 19:4159–4166.
68. Besmer, E., J. Mansilla-Soto, S. Cassard, D.J. Sawchuk, G.
Brown, M. Sadofsky, S.M. Lewis, M.C. Nussenzweig, and
P. Cortes. 1998. Hairpin coding end opening is mediated by
RAG1 and RAG2 proteins. Mol. Cell. 2:817–828.
69. Blunt, T., D. Gell, M. Fox, G.E. Taccioli, A.R. Lehmann,
S.P. Jackson, and P.A. Jeggo. 1996. Identification of a non-
sense mutation in the carboxyl-terminal region of DNA-
dependent protein kinase catalytic subunit in the scid mouse.
Proc. Natl. Acad. Sci. USA. 93:10285–10290.
70. Araki, R., A. Fujimori, K. Hamatani, K. Mita, T. Saito, M.
Mori, R. Fukumura, M. Morimyo, M. Muto, M. Itoh, et al.
1997. Nonsense mutation at Tyr-4046 in the DNA-dependent
protein kinase catalytic subunit of severe combined immune
deficiency mice. Proc. Natl. Acad. Sci. USA. 94:2438–2443.
71. DeFazio, L.G., R.M. Stansel, J.D. Griffith, and G. Chu.
2002. Synapsis of DNA ends by DNA-dependent protein ki-
nase. EMBO J. 21:3192–3200.
72. Jhappan, C., H.C. Morse, III, R.D. Fleischmann, M.M.
Gottesman, and G. Merlino. 1997. DNA-PKcs: a T-cell tu-
mour suppressor encoded at the mouse scid locus. Nat.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
565 Rooney et al.
Genet. 17:483–486.
73. Vanasse, G.J., J. Halbrook, S. Thomas, A. Burgess, M.F.
Hoekstra, C.M. Disteche, and D.M. Willerford. 1999. Ge-
netic pathway to recurrent chromosome translocations in
murine lymphoma involves V(D)J recombinase. J. Clin. In-
vest. 103:1669–1675.
74. Frank, K.M., J.M. Sekiguchi, K.J. Seidl, W. Swat, G.A.
Rathbun, H.L. Cheng, L. Davidson, L. Kangaloo, and F.W.
Alt. 1998. Late embryonic lethality and impaired V(D)J re-
combination in mice lacking DNA ligase IV. Nature. 396:
173–177.
75. Barnes, D.E., G. Stamp, I. Rosewell, A. Denzel, and T.
Lindahl. 1998. Targeted disruption of the gene encoding
DNA ligase IV leads to lethality in embryonic mice. Curr.
Biol. 8:1395–1398.
76. Li, G., C. Nelsen, and E.A. Hendrickson. 2002. Ku86 is es-
sential in human somatic cells. Proc. Natl. Acad. Sci. USA. 99:
832–837.
77. Meek, K., L. Kienker, C. Dallas, W. Wang, M.J. Dark, P.J.
Venta, M.L. Huie, R. Hirschhorn, and T. Bell. 2001. SCID
in Jack Russell terriers: a new animal model of DNA-PKcs
deficiency. J. Immunol. 167:2142–2150.
78. Callebaut, I., D. Moshous, J.P. Mornon, and J.P. de Villartay.
2002. Metallo-beta-lactamase fold within nucleic acids pro-
cessing enzymes: the beta-CASP family. Nucleic Acids Res. 30:
3592–3601.